# Therapeutic role of Crateva religiosa in diabetic nephropathy: Insights into key signaling pathways

**Authors:** Muhammad Ali, Hafiz M. Irfan, Alamgeer, Aman Ullah, Magda H. Abdellattif, Mahmoud Elodemi, Mohammad Zubair, Ajmal Khan, Ahmed Al-Harrasi

PMC · DOI: 10.1371/journal.pone.0324028 · PLOS One · 2025-05-28

## TL;DR

This study explores how Crateva religiosa may help treat diabetic nephropathy by identifying key bioactive compounds and signaling pathways involved.

## Contribution

The study combines computational and empirical methods to identify novel phytoconstituents and their molecular targets in diabetic nephropathy.

## Key findings

- Five phytoconstituents from Crateva religiosa showed potential therapeutic activity in diabetic nephropathy.
- Common targets like AKT1, PPARG, and PTGS2 were found to have strong molecular affinities.
- Key pathways like PI3K-Akt and AGE-RAGE were linked to inflammation and oxidative stress in diabetic nephropathy.

## Abstract

Crateva religiosa, a plant used in traditional medicine, is valued for its bioactive properties. Traditional approaches are more accepted worldwide as a cost effective alternatives being used in network pharmacology to explore the complex interactions of drug targets among molecular pathways. The study investigated the potential of Crateva religiosa’s phytoconstituents using meticulous computational analysis and empirical confirmation. The IMPPAT, GeneCards and DisGeNET data bases were used to obtain the active moieties and disease targets respectively. Crateva phytoconstituent’s DN-target network and protein-protein interaction (PPI) network were developed and analyzed using the STRING online platform and Cytoscape software. GO and KEGG analyses were conducted using the g: profiler databases while the process of molecular docking involved the use of MOE software. The screening process identified dillapiole (CR-C1), beta ionone (CR-C2) 10-epi-γ-eudesmol (CR-C3), cis/trans linalool oxide (CR-C4/5) and nerolidol (CR-C6), as potential active phytoconstituents of C. religiosa and AKT1, PPARG, PTGS2, EGFR, ESR1, JAK2, MAPK1, PARP1, GSK3B, and PPARA as matching targets in DN. The enrichment analysis revealed that the common targets were primarily linked to inflammatory response, oxidative stress, immunological modulation, and cell death. The main signal pathways suggested were PI3K-Akt, AGE-RAGE, and IL-17. Moreover, molecular docking analysis determined that the AKT1, PPARG and PTGS2 are the essential targets that had a good affinity for their respective active molecules.

## Linked entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743], EGFR (epidermal growth factor receptor) [NCBI Gene 1956], ESR1 (estrogen receptor 1) [NCBI Gene 2099], JAK2 (Janus kinase 2) [NCBI Gene 3717], MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142], GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465]
- **Chemicals:** dillapiole (PubChem CID 10231), beta ionone (PubChem CID 638014), 10-epi-γ-eudesmol (PubChem CID 6430754), nerolidol (PubChem CID 8888)
- **Diseases:** diabetic nephropathy (MONDO:0005016)

## Full-text entities

- **Genes:** PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, MOK (MOK protein kinase) [NCBI Gene 5891] {aka RAGE, RAGE-1, RAGE1, STK30}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, RENBP (renin binding protein) [NCBI Gene 5973] {aka RBP, RNBP}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}
- **Diseases:** inflammatory (MESH:D007249), diabetic nephropathy (MESH:D003928)
- **Chemicals:** dillapiole (MESH:C498255), CR-C1 (-), nerolidol (MESH:C037055), beta ionone (MESH:C008157)
- **Species:** Crateva religiosa (sacred garlic pear, species) [taxon 202634]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12118869/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12118869/full.md

## References

102 references — full list in the complete paper: https://tomesphere.com/paper/PMC12118869/full.md

---
Source: https://tomesphere.com/paper/PMC12118869